Is the use of lenalidome better than
Is the use of lenalidome better than  image
Is the use of lenalidome better than
Posted Dec 11, 2013

This is a clinical trial in 278 locations to determine whether treating high-risk smoldering myeloma patients with lenalidomide is better than the "watch and wait" approach using no treatment. Results from a previous trial perfomed by a Spanish group (Dr. Mateos) showed considerable benefit in a similar study, so the study is being run in the U.S. on a large scale to accumulate more data. The study's Principal Investigator is Dr. Sagar Lonial, MD from Dana Farber and the target number of patients to join across the country is 370. More information on this trial, including study locations can be found here.

The author Jennifer Ahlstrom

about the author
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.

More Life with Myeloma Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Bristol Myers Squibb
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811